The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: Characterization and in vitro/in vivo evaluation
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304
Touitou, E., Dayan, N., Bergelson, L., Godin, B., & Eliaz, M. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00222-9 · Cited by 1,345
Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis
Denning, D. W., Ribaud, P., Milpied, N., Caillot, D., Herbrecht, R., Thiel, E., Haas, A., Ruhnke, M., & Lode, H. (2002) · Clinical Infectious Diseases · doi:10.1086/324620 · Cited by 844
Voriconazole: A New Triazole Antifungal Agent
Johnson, L. B., & Kauffman, C. A. (2003) · Clinical Infectious Diseases · doi:10.1086/367933 · Cited by 785
Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections
Perfect, J. R., Marr, K. A., Walsh, T. J., Greenberg, R. N., DuPont, B., de la Torre‐Cisneros, J., Just‐Nubling, G., Schlamm, H. T., Lutsar, I., Espinel‐Ingroff, A., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/374557 · Cited by 680
Lipid vesicles for skin delivery of drugs: Reviewing three decades of research
Elsayed, M. M. A., Abdallah, O. Y., Naggar, V. F., & Khalafallah, N. M. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.12.005 · Cited by 537
Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery
Schreier, H., & Bouwstra, J. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90039-6 · Cited by 532
Cevc, G. (1996) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v13.i3-4.30 · Cited by 506
Jain, S., Jain, P., Umamaheshwari, R. B., & Jain, N. K. (2003) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120025458 · Cited by 408
Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery
Balakrishnan, P., Shanmugam, S., Lee, W. S., Lee, W. M., Kim, J. O., Oh, D. H., Kim, D.-D., Kim, J. S., Yoo, B. K., Choi, H.-G., et al. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.04.020 · Cited by 366
Self-citationMechanism of oleic acid-induced skin penetration enhancement in vivo in humans
Naik, A., Pechtold, L. A. R. M., Potts, R. O., & Guy, R. H. (1995) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00088-7 · Cited by 318
Interaction of liposomes with human skin in vitro — The influence of lipid composition and structure
Kirjavainen, M., Urtti, A., Jääskeläinen, I., Marjukka Suhonen, T., Paronen, P., Valjakka-Koskela, R., Kiesvaara, J., & Mönkkönen, J. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(96)00126-9 · Cited by 252
Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study
Gupta, P. N., Mishra, V., Rawat, A., Dubey, P., Mahor, S., Jain, S., Chatterji, D. P., & Vyas, S. P. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.12.022 · Cited by 236
Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes
El Maghraby, G. M. M., Williams, A. C., & Barry, B. W. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.02.024 · Cited by 227
van den Bergh, B. A. I., Wertz, P. W., Junginger, H. E., & Bouwstra, J. A. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00576-2 · Cited by 222
Elastic liposomes for skin delivery of dipotassium glycyrrhizinate
Trotta, M., Peira, E., Debernardi, F., & Gallarate, M. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00266-1 · Cited by 212
Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in-vitro
El Maghraby, G. M. M., Williams, A. C., & Barry, B. W. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011776450 · Cited by 204
Clinical pharmacokinetics of voriconazole
Levêque, D., Nivoix, Y., Jehl, F., & Herbrecht, R. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.01.003 · Cited by 154
Yamane, M. A., Williams, A. C., & Barry, B. W. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)00312-s · Cited by 151
Phospholipids affect stratum corneum lipid bilayer fluidity and drug partitioning into the bilayers
Kirjavainen, M., Mönkkönen, J., Saukkosaari, M., Valjakka-Koskela, R., Kiesvaara, J., & Urtti, A. O. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00152-7 · Cited by 145
Honeywell‐Nguyen, P. L., & Bouwstra, J. A. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00415-7 · Cited by 133
Ruhnke, M., Schmidt‐Westhausen, A. M., & Trautmann, M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.3.575 · Cited by 126
Novel ultra-deformable vesicles entrapped with bleomycin and enhanced to penetrate rat skin
Hiruta, Y., Hattori, Y., Kawano, K., Obata, Y., & Maitani, Y. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.016 · Cited by 87
Honeywell‐Nguyen, P. L., Frederik, P. M., Bomans, P. H. H., Junginger, H. E., & Bouwstra, J. A. (2002) · Pharmaceutical Research · doi:10.1023/a:1016466406176 · Cited by 78
In Vitro Activity of Voriconazole Against Candida Species
Kauffman, C. A., & Zarins, L. T. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(98)00005-4 · Cited by 38
Cited by
Enhancement strategies for transdermal drug delivery systems: current trends and applications
Ramadon, D., McCrudden, M. T. C., Courtenay, A. J., & Donnelly, R. F. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00909-6 · Cited by 649
Ascenso, A., Batista, C., Cardoso, P., Mendes, T., Praça, F., Bentley, V., Raposo, S., & Simões, S. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s86186 · Cited by 384
Niosomes: A review on niosomal research in the last decade
Bhardwaj, P., Tripathi, P., Gupta, R., & Pandey, S. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101581 · Cited by 366
Rai, S., Pandey, V., & Rai, G. (2017) · Nano Reviews & Experiments · doi:10.1080/20022727.2017.1325708 · Cited by 301
Jain, S., Patel, N., Shah, M. K., Khatri, P., & Vora, N. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.10.001 · Cited by 283
Metadata
- Authors
- Song, C. K., Balakrishnan, P., Shim, C.-K., Chung, S.-J., Chong, S., & Kim, D.-D.
- Venue
- Colloids and Surfaces B: Biointerfaces
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 92
- Pages
- 299-304
- ISSN
- 0927-7765 (ISSN-L)
- OpenAlex
- W2034587896
- Cited by
- 380
- References
- 25
- FWCI
- 2.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.